answer text |
<p>No such assessment has been made. We recognise that late diagnosis of cancers,
including prostate cancer, can impact treatment options, reduce a patient’s chances
of survival, and potentially increase the cost of effective treatments. NHS England
is taking steps to raise awareness of prostate cancer, where there are opportunities
to do so. For example, NHS England partners with Cancer Alliances, charities, and
local representatives to reach people through projects in the heart of their communities.
On 8 January 2024, NHS England also relaunched the Help Us Help You campaign for cancer,
designed to increase earlier diagnosis of cancer by reducing barriers to seeking earlier
help, as well as increasing body vigilance and knowledge of key red flag symptoms.</p><p>Screening
for prostate cancer is currently not recommended by the UK National Screening Committees.
This is because of the inaccuracy of the current best test, the Prostate Specific
Antigen. The UK National Screening Committee is currently undertaking an evidence
review for prostate cancer screening, and plans to report within its three-year work
plan. The evidence review includes modelling of several approaches to prostate cancer
screening, which includes different potential ways of screening the whole population
from 40 years of age onwards, and targeted screening aimed at groups of people identified
as being at higher than average risk, such as black men or men with a family history
of cancer.</p><p>In addition, we are working with Prostate Cancer UK to launch the
TRANSFORM trial. The £42 million nationwide screening study will compare the most
promising tests to look for prostate cancer in men that do not have any symptoms.</p>
|
|